Form4insider filings, from the source

SEC Form 4 · accession 0001104659-18-036488

Kiniksa Pharmaceuticals International, plc · KNSA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Sanj K Patel
Officer — Chairman & CEO · Director
Period of report
May 29, 2018
Accepted (ET)
May 29, 2018 · 7:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001730430

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common SharesMay 29, 2018C135,889$0.00A245,685D
Class A Common Sharesholding———109,795IBy the Manisha S. Patel 2016 Irrevocable Trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series C Preferred SharesF2,F1—Feb 9, 2018P63,922A——Class A Common Shares63,92263,922D
Series A Preferred SharesF3—May 29, 2018C428,203D——Class B Common Shares428,2030D
Series B Preferred SharesF1—May 29, 2018C71,967D——Class A Common Shares71,9670D
Series C Preferred SharesF1—May 29, 2018C63,922D——Class A Common Shares63,9220D
Class B Common SharesF4—May 29, 2018C428,203A——Class A Common Shares428,2031,526,160D

Explanation of responses